Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Hypertens (Greenwich) ; 12(2): 117-24, 2010 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-20167039

RESUMO

The role of increased sympathetic nervous system (SNS) activity in the pathogenesis of obesity hypertension and insulin resistance is controversial. Eight dogs were instrumented and fed a high-fat diet (HFD) for 6 weeks. Dogs were evaluated for changes in weight, blood pressure, insulin resistance, and norepinephrine (NE) kinetics using a two-compartment model. The HFD resulted in weight gain, hypertension, and insulin resistance. During the 6 weeks of the HFD, although plasma NE concentration trended toward increasing (P=.09), SNS, assessed by NE kinetic studies, significantly increased (P=.009). Within 1 week of starting the HFD, NE release into the extravascular compartment (NE(2)) increased from 3.44+/-0.59 microg/mL to 4.87+/-0.80 microg/mL (P<.01) and this increase was maintained over the next 5 weeks of the HFD (NE(2) at week 6 was 4.66+/-0.97 microg/mL). In addition to the increased NE(2) there was also a significant increase in NE clearance (P=.04). There were significant correlations between the increase in NE(2) and both the development of insulin resistance and hypertension. This study supports the hypothesis that activation of the SNS plays a pivotal role in the metabolic and hemodynamic changes that occur with weight gain induced by HFD.


Assuntos
Gorduras na Dieta , Norepinefrina/farmacocinética , Análise de Variância , Animais , Cães , Feminino , Humanos , Hipertensão , Resistência à Insulina , Masculino , Norepinefrina/biossíntese , Norepinefrina/sangue , Fatores de Risco , Estatística como Assunto , Sistema Nervoso Simpático , Aumento de Peso
2.
Hypertension ; 43(5): 1011-6, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15007033

RESUMO

In dogs fed a high-fat diet, we determined whether there was a direct relation between obesity-induced insulin resistance and obesity-induced hypertension. Thirty-six adult mongrel dogs were chronically instrumented and assigned to receive either a high-fat diet alone (n=7) or a high-fat diet combined with a low-sodium diet plus furosemide (n=6), prazosin plus atenolol (n=7), clonidine (n=10), or aspirin (n=6). Blood pressure, heart rate, and body weight were measured daily. Insulin resistance was assessed with a single-dose euglycemic hyperinsulinemic clamp (2 mU x kg(-1) x min(-1)) before and after 1, 3, and 6 weeks of the high-fat diet. The low-salt diet plus furosemide, prazosin plus atenolol, and clonidine treatments prevented the hypertension associated with feeding the dogs a high-fat diet. Only clonidine treatment totally prevented the development of insulin resistance, and high-dose aspirin, known to prevent insulin resistance by inhibition of the activity of IkappaB kinase-beta, decreased the degree of insulin resistance by almost 70%. However, aspirin had no effect on the development of hypertension. We conclude that obesity-induced hypertension and obesity-induced insulin resistance are not directly related. In addition, there is a suggestion that insulin resistance in this experimental model is mediated through the central and or peripheral alpha2-adrenoceptors, whereas hypertension is mediated through the alpha1- and or beta-adrenoceptors.


Assuntos
Hipertensão/etiologia , Resistência à Insulina , Obesidade/complicações , Sistema Nervoso Simpático/fisiopatologia , Antagonistas Adrenérgicos beta/farmacologia , Antagonistas Adrenérgicos beta/uso terapêutico , Animais , Aspirina/uso terapêutico , Atenolol/administração & dosagem , Atenolol/farmacologia , Atenolol/uso terapêutico , Glicemia/análise , Clonidina/farmacologia , Clonidina/uso terapêutico , Dieta Hipossódica , Gorduras na Dieta/toxicidade , Cães , Feminino , Furosemida/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Hipertensão/fisiopatologia , Hipertensão/prevenção & controle , Quinase I-kappa B , Insulina/sangue , Masculino , Modelos Animais , Modelos Biológicos , Obesidade/etiologia , Prazosina/administração & dosagem , Prazosina/farmacologia , Prazosina/uso terapêutico , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Receptores Adrenérgicos beta 1/efeitos dos fármacos , Receptores Adrenérgicos beta 1/fisiologia , Receptores Adrenérgicos beta 2/efeitos dos fármacos , Receptores Adrenérgicos beta 2/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...